{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:48:28Z","timestamp":1777632508657,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202311030"],"award-info":[{"award-number":["SZSM202311030"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Key Laboratory of Inflammatory and Immunology Diseases","award":["ZDSYS20200811143756018"],"award-info":[{"award-number":["ZDSYS20200811143756018"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFE0131700"],"award-info":[{"award-number":["2022YFE0131700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing sci-Tech Program","award":["Z191100006619114"],"award-info":[{"award-number":["Z191100006619114"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82071813"],"award-info":[{"award-number":["82071813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03793-y","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:16:45Z","timestamp":1774063005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum epitope-specific anti-recoverin autoantibodies as biomarkers for lupus retinopathy"],"prefix":"10.1186","volume":"28","author":[{"given":"Min","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuebo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"3793_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1080\/09273948.2018.1501495","volume":"26","author":"R Dammacco","year":"2018","unstructured":"Dammacco R, Procaccio P, Racanelli V, et al. Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers. Ocul Immunol Inflamm. 2018;26:1154\u201365.","journal-title":"Ocul Immunol Inflamm"},{"key":"3793_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10238-017-0479-9","volume":"18","author":"R Dammacco","year":"2018","unstructured":"Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18:135\u201349.","journal-title":"Clin Exp Med"},{"key":"3793_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.sjopt.2016.02.001","volume":"30","author":"SS Shoughy","year":"2016","unstructured":"Shoughy SS, Tabbara KF. Ocular findings in systemic lupus erythematosus. Saudi J Ophthalmol. 2016;30:117\u201321.","journal-title":"Saudi J Ophthalmol"},{"key":"3793_CR4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s41927-021-00203-5","volume":"5","author":"H Bashiri","year":"2021","unstructured":"Bashiri H, Karimi N, Mostafaei S, et al. Retinopathy in newly-diagnosed systemic lupus erythematosus: should we screen for ocular involvement? BMC Rheumatol. 2021;5:34.","journal-title":"BMC Rheumatol"},{"key":"3793_CR5","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/bjophthalmol-2013-303265","volume":"97","author":"YC Yen","year":"2013","unstructured":"Yen YC, Weng SF, Chen HA, et al. Risk of retinal vein occlusion in patients with systemic lupus erythematosus: a population-based cohort study. Br J Ophthalmol. 2013;97:1192\u20136.","journal-title":"Br J Ophthalmol"},{"key":"3793_CR6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3899\/jrheum.111462","volume":"39","author":"RR Butendieck","year":"2012","unstructured":"Butendieck RR, Parikh K, Stewart M, et al. Systemic Lupus Erythematosus-associated Retinal Vasculitis. J Rheumatol. 2012;39:1095\u20136.","journal-title":"J Rheumatol"},{"key":"3793_CR7","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1111\/aos.16640","volume":"102","author":"L Meng","year":"2024","unstructured":"Meng L, Yu Q, Zhao X, et al. Systemic risk factors of retinopathy in patients with systemic lupus erythematosus. Acta Ophthalmol. 2024;102:e774\u201388.","journal-title":"Acta Ophthalmol"},{"key":"3793_CR8","doi-asserted-by":"publisher","first-page":"1395609","DOI":"10.3389\/fimmu.2024.1395609","volume":"15","author":"L Meng","year":"2024","unstructured":"Meng L, Wang Y, Yang Z, et al. Ocular fundus changes and association with systemic conditions in systemic lupus erythematosus. Front Immunol. 2024;15:1395609.","journal-title":"Front Immunol"},{"key":"3793_CR9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/art.1780310904","volume":"31","author":"FJ Staffordbrady","year":"1988","unstructured":"Staffordbrady FJ, Urowitz MB, Gladman DD, et al. Lupus Retinopathy - Patterns, Associations, and Prognosis. Arthritis Rheum. 1988;31:1105\u201310.","journal-title":"Arthritis Rheum"},{"key":"3793_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1046\/j.1442-9071.2004.00766.x","volume":"32","author":"A Au","year":"2004","unstructured":"Au A, O\u2019day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Experimental Ophthalmol. 2004;32:87\u2013100.","journal-title":"Clin Experimental Ophthalmol"},{"key":"3793_CR11","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288\u201391.","journal-title":"J Rheumatol"},{"key":"3793_CR12","doi-asserted-by":"publisher","first-page":"102796","DOI":"10.1016\/j.autrev.2021.102796","volume":"20","author":"E Hysa","year":"2021","unstructured":"Hysa E, Cutolo CA, Gotelli E, et al. Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system. Autoimmun Rev. 2021;20:102796.","journal-title":"Autoimmun Rev"},{"key":"3793_CR13","first-page":"290898","volume":"2012","author":"NV Palejwala","year":"2012","unstructured":"Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898.","journal-title":"Autoimmune Dis"},{"key":"3793_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0049-0172(99)80017-1","volume":"28","author":"A Montehermoso","year":"1999","unstructured":"Montehermoso A, Cervera R, Font J, et al. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Semin Arthritis Rheum. 1999;28:326\u201332.","journal-title":"Semin Arthritis Rheum"},{"key":"3793_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0065-2423(06)42008-4","volume":"42","author":"C Alessandri","year":"2006","unstructured":"Alessandri C, Bombardieri M, Valesini G. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv Clin Chem. 2006;42:297\u2013326.","journal-title":"Adv Clin Chem"},{"key":"3793_CR16","first-page":"109","volume":"27","author":"F Pratesi","year":"2000","unstructured":"Pratesi F, Moscato S, Sabbatini A, et al. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol. 2000;27:109\u201315.","journal-title":"J Rheumatol"},{"key":"3793_CR17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fnmol.2018.00473","volume":"11","author":"J Zang","year":"2018","unstructured":"Zang J, Neuhauss SCF. The Binding Properties and Physiological Functions of Recoverin. Front Mol Neurosci. 2018;11:473.","journal-title":"Front Mol Neurosci"},{"key":"3793_CR18","first-page":"3160","volume":"40","author":"H Ohguro","year":"1999","unstructured":"Ohguro H, Ogawa K, Maeda T, et al. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci. 1999;40:3160\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3793_CR19","first-page":"705","volume":"42","author":"T Maeda","year":"2001","unstructured":"Maeda T, Maeda A, Maruyama I, et al. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 2001;42:705\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3793_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0165-5728(02)00314-4","volume":"132","author":"S Shiraga","year":"2002","unstructured":"Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol. 2002;132:72\u201382.","journal-title":"J Neuroimmunol"},{"key":"3793_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jaut.2005.11.007","volume":"26","author":"G Adamus","year":"2006","unstructured":"Adamus G, Webb S, Shiraga S, et al. Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. J Autoimmun. 2006;26:146\u201353.","journal-title":"J Autoimmun"},{"key":"3793_CR22","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.1073\/pnas.92.20.9176","volume":"92","author":"AS Polans","year":"1995","unstructured":"Polans AS, Witkowska D, Haley TL, et al. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci U S A. 1995;92:9176\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3793_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12348-019-0171-1","volume":"9","author":"S Khanna","year":"2019","unstructured":"Khanna S, Martins A, Oakey Z, et al. Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases. J Ophthalmic Inflamm Infect. 2019;9:6.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3793_CR24","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fimmu.2018.00765","volume":"9","author":"G Adamus","year":"2018","unstructured":"Adamus G. Are Anti-Retinal Autoantibodies a Cause or a Consequence of Retinal Degeneration in Autoimmune Retinopathies? Front Immunol. 2018;9:765.","journal-title":"Front Immunol"},{"key":"3793_CR25","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0002-9394(02)01633-1","volume":"134","author":"H Ohguro","year":"2002","unstructured":"Ohguro H, Maruyama I, Nakazawa M, et al. Antirecoverin antibody in the aqueous humor of a patient with cancer-associated retinopathy. Am J Ophthalmol. 2002;134:605\u20137.","journal-title":"Am J Ophthalmol"},{"key":"3793_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0021-5155(98)00023-9","volume":"42","author":"A Nakamura","year":"1998","unstructured":"Nakamura A, Yokoyama T, Kodera S, et al. Ocular fundus lesions in systemic lupus erythematosus model mice. Jpn J Ophthalmol. 1998;42:345\u201351.","journal-title":"Jpn J Ophthalmol"},{"key":"3793_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/1874364100903010020","volume":"3","author":"X Cao","year":"2009","unstructured":"Cao X, Bishop RJ, Forooghian F, et al. Autoimmune retinopathy in systemic lupus erythematosus: histopathologic features. Open Ophthalmol J. 2009;3:20\u20135.","journal-title":"Open Ophthalmol J"},{"key":"3793_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40942-020-00219-y","volume":"6","author":"A Dias-Santos","year":"2020","unstructured":"Dias-Santos A, Tavares Ferreira J, Pinheiro S, et al. Neurodegeneration in systemic lupus erythematosus: layer by layer retinal study using optical coherence tomography. Int J Retina Vitreous. 2020;6:15.","journal-title":"Int J Retina Vitreous"},{"key":"3793_CR29","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1177\/0961203320940780","volume":"29","author":"M Li","year":"2020","unstructured":"Li M, Cheng G, Wang ZY, et al. Anti-recoverin antibodies indicate fundus abnormalities in systemic lupus erythematosus. Lupus. 2020;29:1346\u201352.","journal-title":"Lupus"},{"key":"3793_CR30","doi-asserted-by":"publisher","first-page":"908459","DOI":"10.3389\/fimmu.2022.908459","volume":"13","author":"SEC Caoili","year":"2022","unstructured":"Caoili SEC. Comprehending B-Cell Epitope Prediction to Develop Vaccines and Immunodiagnostics. Front Immunol. 2022;13:908459.","journal-title":"Front Immunol"},{"key":"3793_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-1-0716-2609-2_12","volume":"2552","author":"D Zheng","year":"2023","unstructured":"Zheng D, Liang S, Zhang C. B-Cell Epitope Predictions Using Computational Methods. Methods Mol Biol. 2023;2552:239\u201354.","journal-title":"Methods Mol Biol"},{"key":"3793_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/(SICI)1097-4547(19960915)45:6<863::AID-JNR23>3.0.CO;2-V","volume":"45","author":"G Adamus","year":"1996","unstructured":"Adamus G, Amundson D. Epitope recognition of recoverin in cancer associated retinopathy: evidence for calcium-dependent conformational epitopes. J Neurosci Res. 1996;45:863\u201372.","journal-title":"J Neurosci Res"},{"key":"3793_CR33","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4049\/jimmunol.1800574","volume":"202","author":"E Nikoopour","year":"2019","unstructured":"Nikoopour E, Lin CM, Sheskey S, et al. Immune Cell Infiltration into the Eye Is Controlled by IL-10 in Recoverin-Induced Autoimmune Retinopathy. J Immunol. 2019;202:1057\u201368.","journal-title":"J Immunol"},{"key":"3793_CR34","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1172\/JCI65292","volume":"123","author":"AJ Roth","year":"2013","unstructured":"Roth AJ, Ooi JD, Hess JJ, et al. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest. 2013;123:1773\u201383.","journal-title":"J Clin Invest"},{"key":"3793_CR35","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"3793_CR36","first-page":"71","volume":"132","author":"TG Burland","year":"2000","unstructured":"Burland TG. DNASTAR\u2019s Lasergene sequence analysis software. Methods Mol Biol. 2000;132:71\u201391.","journal-title":"Methods Mol Biol"},{"key":"3793_CR37","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen MC, Peters B, Nielsen M, et al. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 2017;45:W24\u20139.","journal-title":"Nucleic Acids Res"},{"key":"3793_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha S, Raghava GP. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins. 2006;65:40\u20138.","journal-title":"Proteins"},{"key":"3793_CR39","doi-asserted-by":"publisher","first-page":"103650","DOI":"10.1016\/j.autrev.2024.103650","volume":"23","author":"J Damoiseaux","year":"2024","unstructured":"Damoiseaux J, Bontkes H, Mulder L. Cutting edge confusion about cut-off settings in autoimmune diagnostics. Autoimmun Rev. 2024;23:103650.","journal-title":"Autoimmun Rev"},{"key":"3793_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12348-023-00327-4","volume":"13","author":"D Dhirachaikulpanich","year":"2023","unstructured":"Dhirachaikulpanich D, Chanthongdee K, Zheng Y, et al. A systematic review of OCT and OCT angiography in retinal vasculitis. J Ophthalmic Inflamm Infect. 2023;13:1.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3793_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/0961203309347332","volume":"19","author":"RA Hickman","year":"2010","unstructured":"Hickman RA, Denniston AK, Yee CS, et al. Bilateral retinal vasculitis in a patient with systemic lupus erythematosus and its remission with rituximab therapy. Lupus. 2010;19:327\u20139.","journal-title":"Lupus"},{"key":"3793_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/09273948.2011.603069","volume":"19","author":"E Damato","year":"2011","unstructured":"Damato E, Chilov M, Lee R, et al. Plasma exchange and rituximab in the management of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus. Ocul Immunol Inflamm. 2011;19:379\u201381.","journal-title":"Ocul Immunol Inflamm"},{"key":"3793_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/RHU.0000000000000600","volume":"24","author":"K Tselios","year":"2018","unstructured":"Tselios K, Lam WC, Urowitz MB, et al. Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis. J Clin Rheumatol. 2018;24:93\u20134.","journal-title":"J Clin Rheumatol"},{"key":"3793_CR44","doi-asserted-by":"crossref","unstructured":"Li M, Jin Y, He J. Purtscher-like retinopathy associated with systemic lupus erythematosus treated with rituximab plus low-dose interleukin-2: a case report. Int J Rheum Dis. 2023;26:1373\u20136.","DOI":"10.1111\/1756-185X.14623"},{"key":"3793_CR45","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201321.","journal-title":"N Engl J Med"},{"key":"3793_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/rai2.12125","volume":"4","author":"M Chang","year":"2024","unstructured":"Chang M, Yao K, Hao J, et al. Assessing the causality of interferon-\u03b3 and its receptor 1\/2 with systemic lupus erythematosus risk using genetic data. Rheumatol Autoimmun. 2024;4:109\u201318.","journal-title":"Rheumatol Autoimmun"},{"key":"3793_CR47","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/ard.48.5.358","volume":"48","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Merry P, Acheson JF, et al. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the \u2018primary\u2019 antiphospholipid syndrome. Ann Rheum Dis. 1989;48:358\u201361.","journal-title":"Ann Rheum Dis"},{"key":"3793_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","volume":"42","author":"MF Cusick","year":"2012","unstructured":"Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol. 2012;42:102\u201311.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3793_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08916930500484849","volume":"39","author":"BD Poole","year":"2006","unstructured":"Poole BD, Scofield RH, Harley JB, et al. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006;39:63\u201370.","journal-title":"Autoimmunity"},{"key":"3793_CR50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/IAE.0b013e31826b0c41","volume":"33","author":"MA Cunningham","year":"2013","unstructured":"Cunningham MA, Tarantola RM, Folk JC, et al. Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases. Retina. 2013;33:579\u201385.","journal-title":"Retina"},{"key":"3793_CR51","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/art.10263","volume":"46","author":"F Monneaux","year":"2002","unstructured":"Monneaux F, Muller S. Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. Arthritis Rheum. 2002;46:1430\u20138.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03793-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03793-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03793-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:07:42Z","timestamp":1777435662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03793-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3793"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03793-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Peking University People\u2019s Hospital (Ethics No. 2023PHB434-001) and conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}